[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631826":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":24,"responsibleParty":35,"collaborators":39,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":24,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":24,"enrollmentInfo":55,"targetDuration":24,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":72,"whyStopped":24,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":24},{"fullName":5,"class":6},"The Hong Kong Polytechnic University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ASCC","EXPERIMENTAL","An AI-based sarcoma chatbot building on ChatGPT (ASCC) using a co-design approach.",[13],"Other: ASCC (sarcoma-specific AI chatbot)",{"label":15,"type":6,"description":16,"interventionNames":17},"Control","The standard information from doctor-patient consultations and hospital",[18],"Other: Routine Clinical Care",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"ASCC (sarcoma-specific AI chatbot)","The participants in the experimental group will access the ASCC via a webpage alongside standard information from health professionals for one month (15 minutes weekly).",[9],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Routine Clinical Care","Participants in the control group will receive routine clinical care, including standard information from doctor-patient consultations (e.g., diagnosis, treatment, medical tests) and hospital provided sarcoma and treatment leaflet.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Qi LIU, PhD","CONTACT","85255741349","charlotte-qi.liu@polyu.edu.hk",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","LIU Qi Charlotte","Postdoc fellow",[40,42,44],{"name":41,"class":6},"Queen Mary Hospital, Hong Kong",{"name":43,"class":6},"Prince of Wales Hospital, Shatin, Hong Kong",{"name":45,"class":6},"Queen Elizabeth Hospital, Hong Kong","100631826","information-providing-chatbot-100631826",false,"NCT07505732","Information-providing Chatbot","The Development and Evaluation of a Co-designed, AI-based Information-providing Chatbot for Sarcoma Patients: A Pilot Randomised Controlled Trial","Inclusion Criteria:\n\n* (1) diagnosed with soft tissue sarcoma;\n* (2) receiving active treatment at any stage;\n* (3) aged≥18 years;\n* (4) able to speak Cantonese, Mandarin and English;\n* (5) access to an electronic device enabling ASCC use\n\nExclusion Criteria:\n\n* (1) patients with unstable physical or mental conditions;\n* (2) inability to communicate logically;\n* (3) using chatbots (e.g., ChatGPT, Deepseek) for sarcoma information in the last month;\n* (4) mental health disorders documented by the medical system","ALL","18 Years",{"count":56,"type":57},78,"ESTIMATED","INTERVENTIONAL",[60],"NA","This study aims to develop and examine the feasibility and preliminary effectiveness of an AI-based sarcoma chatbot building on ChatGPT (ASCC) to address the information needs of sarcoma patients. We hypothesized: 1) the ASCC will demonstrate good usability; 2) the study will be feasible in terms of all feasibility indicators; 3) the experimental group will report improved satisfaction and self-efficacy, decreased anxiety and stress than the control groups upon completion of the intervention. The ASCC will be developed using a co-design approach. A pilot randomized controlled trial will then be conducted in the three oncology wards of collaborative hospitals. Seventy-eight sarcoma patients will be recruited and randomized to the experimental group (n=39) and the control group (n=39). The experimental group will use the ASCC available 24\u002F7 via voice or text for disease-related questions for one month while the control group will receive usual care.",[63],"Sarcoma",[65,66,67,68,69,70,71],"sarcoma","health information","artificial intelligence","ChatGPT","chatbot","unmeet needs","cancer","NOT_YET_RECRUITING","2026-03-26",{"date":75,"type":76},"2026-04-01","ACTUAL",{"date":78,"type":57},"2027-04-01",{"date":80,"type":57},"2028-07-31",{"name":5,"class":6}]